IBDEI0LH ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10514,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,10515,0)
 ;;=250.70^^64^685^8
 ;;^UTILITY(U,$J,358.3,10515,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10515,1,4,0)
 ;;=4^250.70
 ;;^UTILITY(U,$J,358.3,10515,1,5,0)
 ;;=5^DM Type II Dm with Peripheral Vasc Dis
 ;;^UTILITY(U,$J,358.3,10515,2)
 ;;=^267843^443.81
 ;;^UTILITY(U,$J,358.3,10516,0)
 ;;=250.01^^64^685^4
 ;;^UTILITY(U,$J,358.3,10516,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10516,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,10516,1,5,0)
 ;;=5^DM Type I DM W/O Complications
 ;;^UTILITY(U,$J,358.3,10516,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,10517,0)
 ;;=272.0^^64^685^22
 ;;^UTILITY(U,$J,358.3,10517,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10517,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,10517,1,5,0)
 ;;=5^Hypercholesterolemia, Pure
 ;;^UTILITY(U,$J,358.3,10517,2)
 ;;=Hypercholesterolemia, Pure^59973
 ;;^UTILITY(U,$J,358.3,10518,0)
 ;;=272.1^^64^685^28
 ;;^UTILITY(U,$J,358.3,10518,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10518,1,4,0)
 ;;=4^272.1
 ;;^UTILITY(U,$J,358.3,10518,1,5,0)
 ;;=5^Hypertriglyceridemia, Pure
 ;;^UTILITY(U,$J,358.3,10518,2)
 ;;=Hypertriglyceridemia, Pure^101303
 ;;^UTILITY(U,$J,358.3,10519,0)
 ;;=272.2^^64^685^24
 ;;^UTILITY(U,$J,358.3,10519,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10519,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,10519,1,5,0)
 ;;=5^Hyperlipidemia, Mixed
 ;;^UTILITY(U,$J,358.3,10519,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,10520,0)
 ;;=275.42^^64^685^21
 ;;^UTILITY(U,$J,358.3,10520,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10520,1,4,0)
 ;;=4^275.42
 ;;^UTILITY(U,$J,358.3,10520,1,5,0)
 ;;=5^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,10520,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,10521,0)
 ;;=275.41^^64^685^29
 ;;^UTILITY(U,$J,358.3,10521,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10521,1,4,0)
 ;;=4^275.41
 ;;^UTILITY(U,$J,358.3,10521,1,5,0)
 ;;=5^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,10521,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,10522,0)
 ;;=276.7^^64^685^23
 ;;^UTILITY(U,$J,358.3,10522,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10522,1,4,0)
 ;;=4^276.7
 ;;^UTILITY(U,$J,358.3,10522,1,5,0)
 ;;=5^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,10522,2)
 ;;=^60042
 ;;^UTILITY(U,$J,358.3,10523,0)
 ;;=275.2^^64^685^19
 ;;^UTILITY(U,$J,358.3,10523,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10523,1,4,0)
 ;;=4^275.2
 ;;^UTILITY(U,$J,358.3,10523,1,5,0)
 ;;=5^Hyper Or Hypomagnesemia
 ;;^UTILITY(U,$J,358.3,10523,2)
 ;;=^35626
 ;;^UTILITY(U,$J,358.3,10524,0)
 ;;=276.0^^64^685^25
 ;;^UTILITY(U,$J,358.3,10524,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10524,1,4,0)
 ;;=4^276.0
 ;;^UTILITY(U,$J,358.3,10524,1,5,0)
 ;;=5^Hypernatremia
 ;;^UTILITY(U,$J,358.3,10524,2)
 ;;=^60144
 ;;^UTILITY(U,$J,358.3,10525,0)
 ;;=276.1^^64^685^32
 ;;^UTILITY(U,$J,358.3,10525,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10525,1,4,0)
 ;;=4^276.1
 ;;^UTILITY(U,$J,358.3,10525,1,5,0)
 ;;=5^Hyponatremia
 ;;^UTILITY(U,$J,358.3,10525,2)
 ;;=Hyponatremia^60722
 ;;^UTILITY(U,$J,358.3,10526,0)
 ;;=275.3^^64^685^20
 ;;^UTILITY(U,$J,358.3,10526,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10526,1,4,0)
 ;;=4^275.3
 ;;^UTILITY(U,$J,358.3,10526,1,5,0)
 ;;=5^Hyper Or Hypophosphatemia
 ;;^UTILITY(U,$J,358.3,10526,2)
 ;;=^93796
 ;;^UTILITY(U,$J,358.3,10527,0)
 ;;=240.0^^64^685^14
 ;;^UTILITY(U,$J,358.3,10527,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10527,1,4,0)
 ;;=4^240.0
 ;;^UTILITY(U,$J,358.3,10527,1,5,0)
 ;;=5^Goiter, Simple
 ;;^UTILITY(U,$J,358.3,10527,2)
 ;;=^259806
 ;;^UTILITY(U,$J,358.3,10528,0)
 ;;=241.1^^64^685^13
 ;;^UTILITY(U,$J,358.3,10528,1,0)
 ;;=^358.31IA^5^2
